MX174376B - Procedimiento para preparar granulos de aspirina de liberacion controlada, de dosis baja - Google Patents

Procedimiento para preparar granulos de aspirina de liberacion controlada, de dosis baja

Info

Publication number
MX174376B
MX174376B MX1888389A MX1888389A MX174376B MX 174376 B MX174376 B MX 174376B MX 1888389 A MX1888389 A MX 1888389A MX 1888389 A MX1888389 A MX 1888389A MX 174376 B MX174376 B MX 174376B
Authority
MX
Mexico
Prior art keywords
procedure
controlled release
low dose
preparing low
release aspirin
Prior art date
Application number
MX1888389A
Other languages
English (en)
Other versions
MX18883A (es
Inventor
Steven Edgar Frisbee
William Neil Charman
Garret Adare Fitzgerald
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/293,832 external-priority patent/US4970081A/en
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of MX18883A publication Critical patent/MX18883A/es
Publication of MX174376B publication Critical patent/MX174376B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
MX1888389A 1989-01-03 1989-12-22 Procedimiento para preparar granulos de aspirina de liberacion controlada, de dosis baja MX174376B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/293,832 US4970081A (en) 1989-01-03 1989-01-03 Controlled-release, low-dose aspirin formulation and method of treating vascular occlusive disease therewith
US42662089A 1989-10-24 1989-10-24

Publications (2)

Publication Number Publication Date
MX18883A MX18883A (es) 1993-09-01
MX174376B true MX174376B (es) 1994-05-11

Family

ID=26968181

Family Applications (1)

Application Number Title Priority Date Filing Date
MX1888389A MX174376B (es) 1989-01-03 1989-12-22 Procedimiento para preparar granulos de aspirina de liberacion controlada, de dosis baja

Country Status (20)

Country Link
EP (1) EP0377439B1 (es)
JP (1) JP2966871B2 (es)
KR (1) KR0151590B1 (es)
AR (1) AR244548A1 (es)
AT (1) ATE127690T1 (es)
AU (1) AU622254B2 (es)
CA (1) CA2006975C (es)
DE (1) DE69022251T2 (es)
DK (1) DK0377439T3 (es)
ES (1) ES2076975T3 (es)
FI (1) FI95776C (es)
GR (1) GR3017576T3 (es)
HK (1) HK35396A (es)
IE (1) IE69270B1 (es)
IL (1) IL92854A (es)
MX (1) MX174376B (es)
MY (1) MY104871A (es)
NO (1) NO177127C (es)
NZ (1) NZ231954A (es)
PT (1) PT92780B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5851579A (en) * 1996-10-28 1998-12-22 Eastman Chemical Company Aqueous enteric coating compositions
PL337813A1 (en) * 1997-06-11 2000-09-11 Procter & Gamble Coated tablet with a coating ensuring safe administration for upper portion of the gastrointestinal tract
JP2008526879A (ja) * 2005-01-06 2008-07-24 シーブイ・セラピューティクス・インコーポレイテッド ラノラジンを含有する徐放性薬学的処方物
WO2008140459A1 (en) * 2007-05-16 2008-11-20 Fmc Corporation Solid form
KR101109633B1 (ko) * 2007-08-03 2012-01-31 제이더블유중외제약 주식회사 활성성분의 코팅막이 보호되는 구강내붕해제형을 제조하기위한 조성물
CA3001288C (en) * 2015-10-09 2022-07-19 Bayer Healthcare Llc Modified release formulation of naproxen sodium
JP7219623B2 (ja) * 2018-01-30 2023-02-08 日東電工株式会社 経皮吸収型製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0064485B1 (en) * 1981-04-27 1985-07-24 Aktiebolaget Hässle New pharmaceutical preparation
GB8519310D0 (en) * 1985-07-31 1985-09-04 Zyma Sa Granular active substances
GB8521494D0 (en) * 1985-08-29 1985-10-02 Zyma Sa Controlled release tablet
AU618589B2 (en) * 1988-04-05 1992-01-02 Kyowa Hakko Kogyo Co. Ltd. Oral compositions for ruminants
US4866046A (en) * 1988-05-31 1989-09-12 Top Laboratories, Inc. Low-dosage sublingual aspirin

Also Published As

Publication number Publication date
MY104871A (en) 1994-06-30
EP0377439A3 (en) 1991-02-06
DK0377439T3 (da) 1995-10-30
NO177127B (no) 1995-04-18
IL92854A (en) 1994-11-28
KR0151590B1 (ko) 1998-10-15
HK35396A (en) 1996-03-08
NO900009D0 (no) 1990-01-02
NZ231954A (en) 1991-12-23
IL92854A0 (en) 1990-09-17
ATE127690T1 (de) 1995-09-15
IE894120L (en) 1990-07-03
KR900011453A (ko) 1990-08-01
JPH02262520A (ja) 1990-10-25
AR244548A1 (es) 1993-11-30
ES2076975T3 (es) 1995-11-16
JP2966871B2 (ja) 1999-10-25
EP0377439B1 (en) 1995-09-13
MX18883A (es) 1993-09-01
DE69022251T2 (de) 1996-05-02
GR3017576T3 (en) 1995-12-31
CA2006975C (en) 2000-04-04
FI900017L (fi) 1990-07-04
FI95776C (fi) 1996-03-25
PT92780B (pt) 1997-12-31
AU622254B2 (en) 1992-04-02
AU4719489A (en) 1990-07-12
FI900017A0 (fi) 1990-01-03
PT92780A (pt) 1990-07-31
NO900009L (no) 1990-07-04
FI95776B (fi) 1995-12-15
CA2006975A1 (en) 1990-07-03
IE69270B1 (en) 1996-08-21
DE69022251D1 (de) 1995-10-19
NO177127C (no) 1995-07-26
EP0377439A2 (en) 1990-07-11

Similar Documents

Publication Publication Date Title
MX161165A (es) Procedimiento para preparar una composicion farmaceutica de liberacion prolongada
MX156495A (es) Procedimiento para preparar una composicion farmaceutica de liberacion prolongada
FI920856A7 (fi) Bioerodoituvia polymeerejä, jotka soveltuvat terapeuttisten aineiden s äädeltyyn vapauttamiseen
NO881164L (no) Substituerte 9-amino-tetrahydroakridiner og relaterte forbindelser, en fremgangsmaate for deres fremstilling og deres bruk som medikamenter.
MX9102500A (es) Compuestos de bifenilio, procedimiento para su preparacion y composicion farmaceutica que los contiene.
DK398583A (da) Spergualin-beslaegtede forbindelser, fremgangsmaader til fremstilling deraf samt deres anvendelse som laegemidler
MX14253A (es) Compuestos de amonio cuaternario, composiciones farmaceuticas que incluyen los compuestos y procedimiento para preparar los compuestos de amonio cuaternario.
MX18883A (es) Procedimiento para preparar granulos de aspirina de libaracion controlada, de dosis baja.
MX17041A (es) Procedimiento para la preparacion de benzopirano pirazoles.
MX154335A (es) Procedimiento para preparar tripolifosfato de sodio granular de baja friabilidad
PT89430A (pt) Dispositivo de localizacao, para operacoes de salvamento
ES525300A0 (es) Procedimiento para preparar derivados de ciclohexano-1,3-biona herbicidas
MX9200333A (es) Procedimiento para preparar dalquilaminopropanodiol
ES1012795Y (es) Pinza para uretrografia.
ES1006813Y (es) Disposicion de seguridad para jeringuillas monouso.
ES1009776Y (es) Cabezal perfeccionado para extintores de incendios.
ES1008276Y (es) Camilla perfeccionada para quiromasaje terapeutico.
ES1011742Y (es) Banda para calzado.
MX9203154A (es) Sistema terapeutico de liberacion regulada para formulaciones farmaceuticas liquidas.
BR1100815A (pt) Compostos, composições farmacêuticas, e, processos para preparar composições farmacêuticas e para preparar compostos
MX13776A (es) Procedimiento para la preparacion de compuestos de subtituidos de tiazodilidindiona.
ES1009964Y (es) Calzado perfeccionado para evitar esguinces de tobillo, principalmentede uso deportivo.
ES1012167Y (es) Union perfeccionada para juegos.
ES1001998Y (es) Banda de seguridad para calzado
ES1006328Y (es) Piso perfeccionado para calzado deportivo.